Arcus Biosciences (RCUS) is down -14.8%, or -$1.94 to $11.16.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RCUS:
- Delta flight crashes in Toronto, Southwest cuts corporate roles: Morning Buzz
- Arcus Biosciences Hold Rating: Balancing Promising Study Data and Strategic Uncertainties
- Arcus Biosciences price target lowered to $18 from $20 at H.C. Wainwright
- Arcus Biosciences price target lowered to $25 from $36 at Morgan Stanley
- Arcus Biosciences retains rights to casdatifan
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue